Overall rank by patents
#26,704
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F41B (WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR).
The verdict
Krysse holds 10 US patents across 2 technology areas, rank #26,704 of 50,000 tracked assignees.
Krysse AS has been granted 10 US utility patents between 2021 and 2024, placing Krysse AS at rank #26,704 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.5 claims per patent with primary concentration in F41B (WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR). As a Foreign Corporation, Krysse AS is one of the more focused assignees in the PatentsView dataset. By volume, Krysse sits between Konoshima Chemical Co., Ltd. (10 patents, rank #26,700) and Kyoto Seisakusho Co., Ltd. (10 patents, rank #26,708) - the closest US assignees by grant volume. The composite Innovation Score of 42.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Krysse AS's 22.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Krysse AS against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Konoshima Chemical Co., Ltd.
10 patents
Krikey, Inc.
10 patents
Kronebusch Industries, LLC
10 patents
Kronos Bio, Inc.
10 patents
Kustom Signals, Inc.
10 patents
Kwangwoon University Research Institute for Industry Cooperation
10 patents
Kyoritsu Chemical & Co., Ltd.
10 patents
Kyoto Seisakusho Co., Ltd.
10 patents
Krysse AS
10 patents
What this shows Krysse holds 10 patents at rank #26,704, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,704 in granted patent volume.
Other assignees with the most granted patents in Krysse's primary technology class.
Krysse's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 30.0% |
| 2022 | 3 | 30.0% |
| 2023 | 3 | 30.0% |
| 2024 | 1 | 10.0% |
Top 2 of 2 technology areas
Overall rank by patents
#26,704
Across all tracked assignees
42.3 out of 100
How to use this portfolio
Krysse's 10 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.